NPS 2390 |
Type I metabotropic glutamate receptor antagonist (IC50s = 5.2 and 82 nM f… |
25 mg |
11989-25 |
More Info
|
NPS 2390 |
Type I metabotropic glutamate receptor antagonist (IC50s = 5.2 and 82 nM f… |
5 mg |
11989-5 |
More Info
|
NPS 2143 (hydrochloride) |
A potent and selective antagonist of CaSR (IC50 = 43 nM) that stimulates P… |
1 mg |
17903-1 |
More Info
|
NPS 2143 (hydrochloride) |
A potent and selective antagonist of CaSR (IC50 = 43 nM) that stimulates P… |
10 mg |
17903-10 |
More Info
|
NPS 2143 (hydrochloride) |
A potent and selective antagonist of CaSR (IC50 = 43 nM) that stimulates P… |
25 mg |
17903-25 |
More Info
|
NPS 2143 (hydrochloride) |
A potent and selective antagonist of CaSR (IC50 = 43 nM) that stimulates P… |
5 mg |
17903-5 |
More Info
|
N-p-Tosyl-Gly-Pro-Lys-pNA (acetate) |
A colorimetric plasmin substrate; hydrolysis releases pNA, which can be qu… |
1 mg |
31544-1 |
More Info
|
N-p-Tosyl-Gly-Pro-Lys-pNA (acetate) |
A colorimetric plasmin substrate; hydrolysis releases pNA, which can be qu… |
10 mg |
31544-10 |
More Info
|
N-p-Tosyl-Gly-Pro-Lys-pNA (acetate) |
A colorimetric plasmin substrate; hydrolysis releases pNA, which can be qu… |
5 mg |
31544-5 |
More Info
|
N-(p-Tosyl)-GPR-pNA (acetate) |
A colorimetric thrombin substrate; cleavage of the GPR peptide sequence re… |
100 mg |
27568-100 |
More Info
|
N-(p-Tosyl)-GPR-pNA (acetate) |
A colorimetric thrombin substrate; cleavage of the GPR peptide sequence re… |
25 mg |
27568-25 |
More Info
|
N-(p-Tosyl)-GPR-pNA (acetate) |
A colorimetric thrombin substrate; cleavage of the GPR peptide sequence re… |
50 mg |
27568-50 |
More Info
|
N-(3-pyridyl)-Indomethacin amide |
N-3PyIA is one of several aromatic amides of indomethacin reported to be p… |
1 mg |
70274-1 |
More Info
|
N-(3-pyridyl)-Indomethacin amide |
N-3PyIA is one of several aromatic amides of indomethacin reported to be p… |
10 mg |
70274-10 |
More Info
|
N-(3-pyridyl)-Indomethacin amide |
N-3PyIA is one of several aromatic amides of indomethacin reported to be p… |
5 mg |
70274-5 |
More Info
|
N-(3-pyridyl)-Indomethacin amide |
N-3PyIA is one of several aromatic amides of indomethacin reported to be p… |
50 mg |
70274-50 |
More Info
|
N-Pyrrolidino Etodesnitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
1 mg |
38126-1 |
More Info
|
N-Pyrrolidino Etodesnitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
5 mg |
38126-5 |
More Info
|
N-Pyrrolidino Etonitazene |
An analytical reference standard categorized as an opioid; regulated as a… |
1 mg |
33169-1 |
More Info
|
N-Pyrrolidino Etonitazene |
An analytical reference standard categorized as an opioid; regulated as a… |
5 mg |
33169-5 |
More Info
|
N-Pyrrolidino Etonitazene-d5 |
An internal standard for the quantification of N-pyrrolidino etonitazene b… |
1 mg |
38173-1 |
More Info
|
N-Pyrrolidino Etonitazene-d5 |
An internal standard for the quantification of N-pyrrolidino etonitazene b… |
5 mg |
38173-5 |
More Info
|
N-Pyrrolidino Etonitazene (exempt preparation) |
An analytical reference standard categorized as an opioid; provided as an… |
1 mg |
38255-1 |
More Info
|
N-Pyrrolidino 4'-hydroxy Nitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
1 mg |
37834-1 |
More Info
|
N-Pyrrolidino 4'-hydroxy Nitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
5 mg |
37834-5 |
More Info
|
N-Pyrrolidino Isotonitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
1 mg |
34909-1 |
More Info
|
N-Pyrrolidino Isotonitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
5 mg |
34909-5 |
More Info
|
N-Pyrrolidino Metodesnitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
1 mg |
38127-1 |
More Info
|
N-Pyrrolidino Metodesnitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
5 mg |
38127-5 |
More Info
|
N-Pyrrolidino Metonitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
1 mg |
37685-1 |
More Info
|
N-Pyrrolidino Metonitazene (citrate) |
An analytical reference standard that is structurally similar to known opi… |
5 mg |
37685-5 |
More Info
|
N-Pyrrolidino Protonitazene |
An analytical reference standard that is structurally similar to known opi… |
1 mg |
37456-1 |
More Info
|
N-Pyrrolidino Protonitazene |
An analytical reference standard that is structurally similar to known opi… |
5 mg |
37456-5 |
More Info
|
N-pyrrolidinyl-3,4-DMA (hydrochloride) |
An analytical reference standard categorized as an amphetamine; intended f… |
1 mg |
30611-1 |
More Info
|
N-pyrrolidinyl-3,4-DMA (hydrochloride) |
An analytical reference standard categorized as an amphetamine; intended f… |
5 mg |
30611-5 |
More Info
|
NQ301 |
A naphthoquinone with diverse biological activities; inhibits U-46619-indu… |
1 mg |
21958-1 |
More Info
|
NQ301 |
A naphthoquinone with diverse biological activities; inhibits U-46619-indu… |
10 mg |
21958-10 |
More Info
|
NQ301 |
A naphthoquinone with diverse biological activities; inhibits U-46619-indu… |
25 mg |
21958-25 |
More Info
|
NQ301 |
A naphthoquinone with diverse biological activities; inhibits U-46619-indu… |
5 mg |
21958-5 |
More Info
|
NQDI-1 |
A selective inhibitor of ASK1 (IC50 = 3 µM; Ki = 500 nM); promotes s… |
1 mg |
16226-1 |
More Info
|
NQDI-1 |
A selective inhibitor of ASK1 (IC50 = 3 µM; Ki = 500 nM); promotes s… |
10 mg |
16226-10 |
More Info
|
NQDI-1 |
A selective inhibitor of ASK1 (IC50 = 3 µM; Ki = 500 nM); promotes s… |
25 mg |
16226-25 |
More Info
|
NQDI-1 |
A selective inhibitor of ASK1 (IC50 = 3 µM; Ki = 500 nM); promotes s… |
5 mg |
16226-5 |
More Info
|
NQTrp |
An inhibitor of Aβ oligomerization and fibrillization (IC50 = 50 nM f… |
1 mg |
19127-1 |
More Info
|
NQTrp |
An inhibitor of Aβ oligomerization and fibrillization (IC50 = 50 nM f… |
10 mg |
19127-10 |
More Info
|
NQTrp |
An inhibitor of Aβ oligomerization and fibrillization (IC50 = 50 nM f… |
25 mg |
19127-25 |
More Info
|
NQTrp |
An inhibitor of Aβ oligomerization and fibrillization (IC50 = 50 nM f… |
5 mg |
19127-5 |
More Info
|
NR-160 |
An inhibitor of HDAC6 (IC50 = 0.03 µM); selective for HDAC6 over HDA… |
1 mg |
31792-1 |
More Info
|
NR-160 |
An inhibitor of HDAC6 (IC50 = 0.03 µM); selective for HDAC6 over HDA… |
10 mg |
31792-10 |
More Info
|
NR-160 |
An inhibitor of HDAC6 (IC50 = 0.03 µM); selective for HDAC6 over HDA… |
5 mg |
31792-5 |
More Info
|